The CDSCO SUGAM portal (cdscoonline.gov.in) is India's official centralised online platform for all regulatory submissions to the Central Drugs Standard Control Organization (CDSCO). SUGAM stands for System for Unmanned Gateways Approval of Manufacturers. It is the mandatory digital route for manufacturers, importers, and researchers applying for licenses, registrations, and approvals across drugs, medical devices, cosmetics, clinical trials, biologicals, and blood products. No paper submissions are accepted. Registration requires an authorisation letter, company incorporation certificate, and identity proof. Applications with unanswered CDSCO queries are rejected after 90 days. Foreign companies must appoint an Authorised Indian Representative (AIR) to use the portal.
For any company seeking to manufacture, import, or sell drugs, medical devices, or cosmetics in India, there is one unavoidable starting point: the CDSCO SUGAM portal. This is the official digital gateway through which the Central Drugs Standard Control Organization (CDSCO) receives all regulatory applications — from manufacturing licenses and import approvals to clinical trial permissions and batch release certificates. Understanding how to navigate SUGAM correctly is not optional; it is the foundation of every regulatory strategy for the Indian market.
Despite its central role, SUGAM trips up a significant number of applicants — through incomplete account registration, mismatched document details, missed query notifications, or applications submitted under the wrong regulatory pathway. These errors are preventable. This guide explains exactly what the CDSCO SUGAM portal is, how to register correctly, what documents are required, and which regulatory divisions it handles — so that your application enters the review queue in the best possible position.
📑 Quick Navigation
- What is the CDSCO SUGAM Portal?
- Why SUGAM Exists — The Regulatory Context
- Regulatory Divisions Covered by SUGAM
- Documents Required for SUGAM Registration
- 5-Step SUGAM Registration Process
- The 90-Day Query Rejection Rule
- Applicant Types on SUGAM
- How Rego Services Supports SUGAM Submissions
- Frequently Asked Questions
What is the CDSCO SUGAM Portal?
The CDSCO SUGAM portal is India's official online platform for regulatory submissions to the Central Drugs Standard Control Organization — the national body responsible for regulating drugs, medical devices, cosmetics, diagnostics, and clinical trials in India. The portal's full name is the System for Unmanned Gateways Approval of Manufacturers. It is accessible at cdscoonline.gov.in.
SUGAM functions as a single-window digital system that consolidates all regulatory submissions under one platform. Whether a company is applying for a drug manufacturing license, a medical device import registration, a cosmetics manufacturing certificate, or a clinical trial approval, the submission route is the same: a SUGAM account, the correct application form, the requisite supporting documents, and the applicable government fee — all managed through the portal's interface.
Why SUGAM Exists — The Regulatory Context
Before SUGAM, regulatory submissions to CDSCO involved physical dossiers, courier documentation, manual tracking, and in-person follow-up. The process was opaque, inconsistent between states and central offices, and frequently slow. SUGAM was created to solve these structural problems — by digitalising the entire submission and review workflow, creating a single verifiable record of every application, and enabling real-time status tracking by both applicants and regulators.
Every application, query, response, and decision is recorded on the portal with timestamps. This creates an auditable regulatory trail for both the applicant and CDSCO. Applicants can track the real-time status of their submission and see exactly where it is in the review queue — eliminating the need for informal follow-up channels.
Digital submission eliminates the transit and manual logging delays of paper-based filing. Queries raised by the State Licensing Authority or CDSCO are delivered instantly through the portal, and responses can be submitted without the delay of physical courier. For applicants who monitor the portal actively, this compresses the effective review timeline.
By requiring document upload and institutional verification at account registration, SUGAM reduces the risk of fraudulent submissions. The portal's identity verification step ensures that only legitimate entities — with correctly matched legal identity documents — gain access to regulatory filing capabilities.
SUGAM applies the same regulatory submission standards across all states. Whether a manufacturing license application is reviewed by Maharashtra's State Licensing Authority or Himachal Pradesh's, the application format, document requirements, and process steps are standardised through the portal — reducing variation in expectations between different regulatory offices.
SUGAM is part of India's broader initiative to improve ease of doing business for domestic and international companies in regulated sectors. Foreign companies can now manage their Indian regulatory submissions remotely through their Authorised Indian Representative, without requiring physical presence at CDSCO offices for routine applications.
All application documents submitted through SUGAM are stored on the portal — eliminating the risk of physical dossier loss and creating a centralised record that can be referenced for subsequent applications, variation filings, and compliance audits. Companies with multiple products and ongoing regulatory filings benefit significantly from this consolidated document repository.
Regulatory Divisions Covered by SUGAM
SUGAM is not limited to a single product category or regulatory function. It serves as the submission gateway across the full scope of CDSCO's regulatory mandate. Understanding which division your product or application falls under is essential before beginning account registration — the applicant type and application pathway differ by category.
| Regulatory Division | What It Covers | Key License / Form | Authority |
|---|---|---|---|
| Drugs | New drug approvals, manufacturing licenses, import licenses for pharmaceuticals | Form 25 (non-biological mfg), Form 28 (biological mfg) | CDSCO / State FDA |
| Medical Devices & IVDs | Manufacturing and import licenses for Class A–D medical devices and in vitro diagnostics | MD-5 / MD-9 (mfg), MD-15 (import), MD-3 / MD-4 (forms) | SLA (Class A/B), CDSCO (Class C/D) |
| Cosmetics | Import and manufacturing licenses for cosmetic products under the Cosmetics Rules | Form COS-2 (import), Form COS-8 (manufacturing) | CDSCO / State Authority |
| Clinical Trials | Permissions for conducting human and veterinary clinical trials in India | Protocol submission, ethics committee clearance | CDSCO |
| Biologicals | Manufacturing, import, and batch release for vaccines and r-DNA products | Specialised biologicals forms | CDSCO |
| Blood & Blood Products | Blood bank licensing, sera, IV fluids — specialised CDSCO licenses | Specialised blood product forms | CDSCO |
| BA/BE Studies | Bioavailability and bioequivalence study approvals for generic drug development | Protocol submission, ethics committee records | CDSCO |
| Ethics Committees | Registration and regulatory oversight of ethics committees for clinical research | Ethics committee registration forms | CDSCO |
Documents Required for SUGAM Registration
SUGAM account registration — the step that creates your company's identity on the portal — requires a foundational set of documents to verify the applicant's legal identity. These are separate from the product-specific and facility documents required for the individual license applications you will file after your account is active.
- Authorisation letter — Issued by the company on its official letterhead with company seal, authorising the named representative to act on the company's behalf for SUGAM registrations and submissions. The authorised person's name and designation must match the identity proof submitted. The letter must be signed by an authorised signatory of the company — typically a Director or Managing Director.
- Company incorporation certificate — Proof of legal existence of the applicant organisation, issued by the Registrar of Companies (for Indian companies) or equivalent authority. Must show the company's registered legal name, CIN (Company Identification Number), and date of incorporation. The legal name on this certificate must exactly match the name entered during portal registration — any variation generates a verification failure.
- Identity proof of the applicant representative — A government-issued photo identity document of the individual named in the authorisation letter: Aadhaar card, PAN card, or Passport. Must be valid at the time of submission. The name and details must match those in the authorisation letter exactly.
- Power of Attorney (where applicable) — Required where the authorised representative's authority over regulatory submissions derives from a formal Power of Attorney arrangement rather than a standard employment authorisation letter. Relevant for consultants, law firms, or regulatory affairs agencies acting on behalf of clients.
ECG Machine Manufacturing License — CDSCO MD5 Complete Guide 2026
If you are registering on SUGAM to apply for a medical device manufacturing license, this guide covers the complete MD5 license process for Class B active diagnostic devices — including the full document checklist, Device Master File requirements, ISO 13485 certification, and the 9-step SUGAM application process.
5-Step SUGAM Registration Process
Creating a SUGAM account is a structured online process. Every field and every document submitted at this stage forms the legal identity your company will use for all future regulatory submissions with CDSCO. Accuracy at this step — particularly in matching company name, address, and representative details to the underlying documents — directly determines how smoothly your subsequent license applications proceed.
Navigate directly to cdscoonline.gov.in. Do not access the SUGAM portal through third-party links, aggregator websites, or unofficial redirects — only the official URL ensures you are interacting with CDSCO's authentic platform. On the homepage, locate the Sign Up or New Registration option. Before proceeding, confirm that your company name is available and matches the incorporation documents you will upload — the portal may flag name conflicts with existing registered entities.
Click Sign Up to begin. Enter your organisation's full legal name exactly as it appears on your incorporation certificate — including punctuation, abbreviations (Pvt. Ltd., LLP, etc.), and spacing. Select the correct applicant type from the portal's dropdown: manufacturer, importer, distributor, Contract Research Organisation (CRO), sponsor, ethics committee, or formulation R&D organisation. For foreign companies, this is the step where the Authorised Indian Representative (AIR) details are entered — the AIR's Indian entity becomes the portal account holder acting on the foreign company's behalf. Enter the authorised representative's details, registered company address, and contact information. Every field must be traceable to a corresponding document in the upload set.
Upload the authorisation letter, company incorporation certificate, and identity proof of the authorised representative in the file formats and size limits specified by the portal (typically PDF, under 2MB per file). Before uploading, verify that: (a) the company name in the incorporation certificate matches the name entered in Step 2 exactly, (b) the representative's name on the authorisation letter matches the identity proof exactly, and (c) all documents are current — expired documents will fail verification. File naming conventions matter on SUGAM — use clear, descriptive file names that match the document type.
Once the registration form and documents are submitted, CDSCO officials review the account application for document authenticity, identity consistency, and completeness. If everything is in order, the account is verified and activated. Login credentials — username and a temporary password — are sent to the registered email address. If CDSCO identifies a discrepancy in the registration documents, they may raise a query through the portal or via the registered email. Monitor both channels during the verification period. Account activation typically occurs within a few working days of a complete, accurate submission.
After activation, log in with the credentials provided and immediately change the temporary password to a secure one. Access the portal dashboard and familiarise yourself with the navigation structure — the application categories correspond to the regulatory divisions (drugs, medical devices, cosmetics, etc.). Select the relevant category for your first submission and begin the application form. The portal dashboard also displays your active applications, their current review status, any pending queries, and upcoming compliance deadlines. Assign a dedicated team member to monitor this dashboard regularly — missed query notifications are one of the most common causes of the 90-day rejection rule being triggered.
The 90-Day Query Rejection Rule
CDSCO introduced a rule that has significant operational implications for all SUGAM applicants: applications with unanswered queries on the portal are automatically rejected after 90 days. This is not a discretionary measure — it is a built-in portal mechanism that triggers without any additional action by the State Licensing Authority or CDSCO.
SUGAM sends query notifications to the registered email address. If the email is no longer monitored, goes to a spam folder, or the registered address is incorrect, the notification is never seen. The 90-day clock runs regardless. Always use an actively monitored email address for portal registration and check the portal dashboard directly at least weekly.
Responding to a query with an incomplete or insufficient document does not reset the 90-day clock in all cases — the SLA may raise a follow-on query, and the overall response timeline still applies. Ensure every query response is complete, accurate, and accompanied by all requested evidence before submission.
Some applications attract multiple sequential queries — each requiring a response. If one query in a sequence goes unaddressed while others are being answered, the unaddressed query's clock continues independently. Monitor every open query item on the portal dashboard simultaneously, not just the most recent one.
When the team member responsible for SUGAM monitoring leaves the company or changes roles, query notifications can go unmonitored during the transition period. Always maintain at least two internal contacts or a regulatory affairs partner with access to the portal and responsibility for query monitoring — with no single point of failure in the monitoring chain.
Applicant Types on SUGAM
The SUGAM portal supports multiple applicant categories, each with distinct registration requirements and access to different application pathways. Selecting the correct applicant type at registration is important — it determines which forms and workflows are available to your account.
| Applicant Type | Who Uses It | Typical Applications | Key Note |
|---|---|---|---|
| Manufacturer (Indian) | Indian companies producing drugs, devices, or cosmetics | MD-5, MD-9, Form 25, COS-8 — manufacturing licenses | Must have declared manufacturing facility in India |
| Importer | Indian companies importing foreign products for sale in India | MD-15, Form 28, COS-2 — import licenses and registrations | Must hold a valid wholesale license for the relevant category |
| Foreign Manufacturer (via AIR) | Overseas companies seeking Indian market access | Device registration, drug import, cosmetics import | Authorised Indian Representative (AIR) is mandatory |
| Distributor | Distribution companies managing the supply chain | Wholesale and distribution license filings | Limited application access versus manufacturers |
| Contract Research Organisation (CRO) | Clinical research organisations conducting trials | Clinical trial applications, BA/BE studies | Must be registered and recognised by CDSCO |
| Ethics Committee | Institutional ethics committees overseeing research | Ethics committee registration and annual reporting | Registration mandatory for oversight of CDSCO-regulated trials |
ISO 13485 Certification in India 2026 — Complete Guide
If you are registering on SUGAM to apply for a CDSCO medical device manufacturing license, your ISO 13485 certificate is a mandatory document for the application. This guide explains the 8 ISO 13485 clauses, the 10-step certification process, and how Rego Services supports manufacturers through the complete QMS documentation and audit preparation process.
How Rego Services Supports SUGAM Submissions
Rego Services Private Limited provides complete regulatory support for SUGAM-based submissions across all CDSCO categories. Our team manages the full lifecycle of regulatory applications on the portal — from initial account registration through document preparation, submission, query response, and license receipt.
- SUGAM account registration — We handle the full portal account setup — verifying company identity documents, preparing the authorisation letter, uploading registration documents in the correct format, and coordinating the CDSCO verification process. We ensure the account is registered under the correct applicant type and with details that match all downstream application documents.
- Regulatory pathway identification — Before any application is filed, we confirm the correct CDSCO category, license type, and form for your specific product. For medical devices, this includes classification confirmation. For drugs, this includes determining whether new drug or existing drug pathways apply. For cosmetics, this covers import versus manufacturing license selection.
- Application dossier preparation — We prepare the complete document set for each application — Device Master Files, Plant Master Files, ISO 13485 coordination, batch records, facility layouts, personnel documentation, NOCs, and all other category-specific requirements. Documents are prepared to CDSCO standards and cross-checked for internal consistency before upload.
- SUGAM portal submission management — We manage the complete portal submission — form completion, document upload in the correct format and file structure, fee payment coordination, and submission confirmation. We verify that the application reference number is received and that the application status shows as active in the SLA review queue.
- Query monitoring and response — We maintain active monitoring of the SUGAM portal for all client applications. When queries are raised by the State Licensing Authority or CDSCO, we prepare complete, accurate, evidence-based responses and submit them well within the 90-day window. No client application has lapsed under the query rejection rule under our management.
- Inspection preparation — Where the SLA schedules a facility inspection as part of the license review, we prepare the facility team — verifying that physical conditions match the Plant Master File, briefing personnel on inspector interaction protocols, and conducting mock inspection walkthroughs.
- Post-grant compliance — After license grant, we support ongoing SUGAM-based compliance — retention fee scheduling, adverse event reporting, variation applications for new products or facility changes, and license renewal filings as required.
Frequently Asked Questions
Does one SUGAM account cover all product categories?
A single SUGAM account can cover multiple product categories and multiple applications — provided the account is registered under the correct applicant type that encompasses all the regulatory pathways you intend to use. A manufacturer who makes both drugs and medical devices would file applications under different sections of the portal from the same account. However, if your company's regulatory activities span significantly different applicant types — for example, both manufacturing and clinical research sponsorship — confirm with Rego Services whether a single account structure is appropriate for your full regulatory footprint.
Is the SUGAM portal the same as the CDSCO website?
The CDSCO website (cdsco.gov.in) and the SUGAM portal (cdscoonline.gov.in) are related but distinct systems. The CDSCO website is the general information and public access portal — it publishes guidelines, approved product lists, drug alerts, and regulatory guidance documents. The SUGAM portal is the operational transaction system — it is where applications are filed, fees are paid, documents are submitted, and licenses are issued. Regulatory applications are always filed through SUGAM, not through the CDSCO public website.
How long does SUGAM account verification take?
CDSCO account verification timelines vary depending on submission completeness and current workload, but accounts with complete, accurate, and consistent documentation are typically activated within a few working days of submission. Incomplete registrations — where documents do not match the form entries or uploaded files do not meet portal specifications — may be queried, extending the verification period. Rego Services prepares SUGAM registrations to minimise verification time through thorough pre-submission document review.
What should I do if I receive a query on SUGAM that I do not understand?
CDSCO queries can range from requests for specific additional documentation to technical questions about product specifications, manufacturing processes, or personnel qualifications. If the query is unclear or the appropriate response is uncertain, do not submit a partial or speculative response — an inadequate response may trigger a further query and erode your 90-day window. Contact Rego Services with the query text: we will interpret the regulatory basis for the query and prepare a complete, technically accurate response that addresses what the SLA is actually asking for.
Can a regulatory consultant register and manage SUGAM on behalf of a company?
Yes. A regulatory consultant or consulting firm can manage SUGAM submissions on behalf of a company through a properly executed Power of Attorney or authorisation letter. The account is registered in the company's legal name, with the consultant named as the authorised representative. Rego Services operates in this capacity for clients — managing the complete SUGAM account and submission lifecycle as the company's authorised regulatory representative, while all licenses are issued in the client company's name.
✓ Key Takeaways
- The CDSCO SUGAM portal (cdscoonline.gov.in) is India's mandatory digital gateway for all regulatory submissions to CDSCO — no paper applications are accepted
- SUGAM stands for System for Unmanned Gateways Approval of Manufacturers and covers drugs, medical devices, cosmetics, clinical trials, biologicals, blood products, BA/BE studies, and ethics committees
- Account registration requires an authorisation letter, company incorporation certificate, and identity proof — all details must match exactly across documents and portal entries
- Foreign companies must appoint an Authorised Indian Representative (AIR) — the AIR registers the SUGAM account and acts as the regulatory liaison in India
- Applications with unanswered CDSCO queries are automatically rejected after 90 days — active portal monitoring is not optional; it is operationally critical
- Medical device manufacturing licenses are filed under MD-5 (Class A/B) or MD-9 (Class C/D); import licenses under MD-15; all via SUGAM
- Selecting the correct applicant type at registration determines which application pathways are accessible — verify this before creating the account
- Rego Services manages the complete SUGAM process — account registration, dossier preparation, portal submission, query monitoring and response, and post-grant compliance tracking
Your Next Step
The CDSCO SUGAM portal is the foundation of every regulatory strategy for the Indian market. Whether you are a domestic manufacturer applying for an MD5 manufacturing license, a foreign device company seeking import registration, or a pharma company managing drug approvals, every application flows through this single system — and every compliance obligation is tracked here.
Getting SUGAM right from the outset — correct account registration, correct applicant type, fully consistent documentation — saves significant time and cost downstream. The 90-day rejection rule means that applicants who approach SUGAM without a structured monitoring process face real risk of losing an in-progress application and restarting from scratch.
Rego Services has managed SUGAM submissions across drug, medical device, and cosmetics categories for manufacturers and importers across India. Our team knows what account verification, application review, and query response look like from the inside of the portal — and we build that operational knowledge into every submission we manage.
Contact Rego Services today to confirm your SUGAM pathway, prepare your account registration documents, and put a structured submission management process in place before your first application is filed.